Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roddy Walsh

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 18, 2016
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samplesRoddy Walsh, Kate L Thomson, James S Ware, et al.
European Heart Journal|January 14, 2017
Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genesRoddy Walsh, Rachel Buchan, Alicja Wilk, et al.
European Heart Journal|July 11, 2023
Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathyMona Allouba, Roddy Walsh, Alaa Afify, et al.
Journal of Cardiovascular Translational Research|February 19, 2016
Development of a Comprehensive Sequencing Assay for Inherited Cardiac Condition GenesChee Jian Pua, Jaydutt Bhalshankar, Kui Miao, et al.
American Journal of Human Genetics|January 5, 2019
Using High-Resolution Variant Frequencies Empowers Clinical Genome Interpretation and Enables Investigation of Genetic ArchitectureNicola Whiffin, Angharad M Roberts, Eric Minikel, et al.
European Heart Journal|September 24, 2021
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic deathRoddy Walsh, Arnon Adler, Ahmad S Amin, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: phenotypes linked by truncating variants in <i>NDUFB11</i>Gillian Rea, Tessa Homfray, Jan Till, et al.
European Journal of Heart Failure|December 30, 2021
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Rudolf A de Boer, Stephane Heymans, Johannes Backs, et al.
Journal of the American College of Cardiology|October 28, 2017
Phenotype and Clinical Outcomes of Titin CardiomyopathyUpasana Tayal, Simon Newsome, Rachel Buchan, et al.
Circulation|August 30, 2021
New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic CardiomyopathyYasmine Aguib, Mona Allouba, Roddy Walsh, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 18, 2016
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samplesRoddy Walsh, Kate L Thomson, James S Ware, et al.
European Heart Journal|January 14, 2017
Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genesRoddy Walsh, Rachel Buchan, Alicja Wilk, et al.
European Heart Journal|July 11, 2023
Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathyMona Allouba, Roddy Walsh, Alaa Afify, et al.
Journal of Cardiovascular Translational Research|February 19, 2016
Development of a Comprehensive Sequencing Assay for Inherited Cardiac Condition GenesChee Jian Pua, Jaydutt Bhalshankar, Kui Miao, et al.
American Journal of Human Genetics|January 5, 2019
Using High-Resolution Variant Frequencies Empowers Clinical Genome Interpretation and Enables Investigation of Genetic ArchitectureNicola Whiffin, Angharad M Roberts, Eric Minikel, et al.
European Heart Journal|September 24, 2021
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic deathRoddy Walsh, Arnon Adler, Ahmad S Amin, et al.
Cold Spring Harbor Molecular Case Studies|January 5, 2017
Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: phenotypes linked by truncating variants in <i>NDUFB11</i>Gillian Rea, Tessa Homfray, Jan Till, et al.
European Journal of Heart Failure|December 30, 2021
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)Rudolf A de Boer, Stephane Heymans, Johannes Backs, et al.
Journal of the American College of Cardiology|October 28, 2017
Phenotype and Clinical Outcomes of Titin CardiomyopathyUpasana Tayal, Simon Newsome, Rachel Buchan, et al.
Circulation|August 30, 2021
New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic CardiomyopathyYasmine Aguib, Mona Allouba, Roddy Walsh, et al.
Pageof 9